ARTICLE | Company News
Neurogen, Pfizer deal
January 8, 2001 8:00 AM UTC
The companies extended their 1992 GABA receptor collaboration to develop therapeutics for anxiety, Alzheimer's disease and insomnia. Under the extension, NRGN will receive an additional $2.9 million ...